TIRZ – GLP2
Dual incretin receptor research peptide
Tirzepatide is a synthetic 39–amino acid peptide analogue investigated in clinical research for its dual agonist activity at the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This dual incretin receptor profile has been studied in published trials for its effects on glucose regulation and metabolic pathways. BlankChem supplies Tirzepatide exclusively as a high-purity research standard intended for controlled laboratory applications.
Form: Lyophilized peptide powder
Available Sizes: 10 mg
Purity: ≥99% (HPLC verified)
Appearance: White to off-white lyophilized solid
Solubility: Water or aqueous buffers
Storage: -20°C recommended for long-term stability
Important Notice:
For research use only (RUO). Not for human consumption. Not for diagnostic, therapeutic, or veterinary use.
